Page last updated: 2024-09-03

1-(4-methoxyphenyl)pyridinium and n-(1-methylethyl)-1,1,2-trimethylpropylamine

1-(4-methoxyphenyl)pyridinium has been researched along with n-(1-methylethyl)-1,1,2-trimethylpropylamine in 1 studies

Compound Research Comparison

Studies
(1-(4-methoxyphenyl)pyridinium)
Trials
(1-(4-methoxyphenyl)pyridinium)
Recent Studies (post-2010)
(1-(4-methoxyphenyl)pyridinium)
Studies
(n-(1-methylethyl)-1,1,2-trimethylpropylamine)
Trials
(n-(1-methylethyl)-1,1,2-trimethylpropylamine)
Recent Studies (post-2010) (n-(1-methylethyl)-1,1,2-trimethylpropylamine)
550171331

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, JH; Hu, G; Sun, XL; Zhang, S; Zhou, F; Zhou, XQ1

Other Studies

1 other study(ies) available for 1-(4-methoxyphenyl)pyridinium and n-(1-methylethyl)-1,1,2-trimethylpropylamine

ArticleYear
ATP-sensitive potassium channel opener iptakalim protects against MPP-induced astrocytic apoptosis via mitochondria and mitogen-activated protein kinase signal pathways.
    Journal of neurochemistry, 2007, Volume: 103, Issue:2

    Topics: Animals; Apoptosis; Astrocytes; Blotting, Western; Cells, Cultured; Cytochromes c; Flow Cytometry; Glutathione; JNK Mitogen-Activated Protein Kinases; Membrane Potentials; Mitochondria; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Phosphorylation; Propylamines; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Signal Transduction

2007